Trial Profile
Sofosbuvir-based therapy in patients with hepatitis C under real life conditions in Germany
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Dec 2015
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary) ; Peginterferon; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms SOFGER
- 08 Dec 2015 New trial record